A share price of Veracyte Inc [VCYT] is currently trading at $41.10, up 3.81%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VCYT shares have gain 11.96% over the last week, with a monthly amount glided 24.43%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Veracyte Inc [NASDAQ: VCYT] stock has seen the most recent analyst activity on November 15, 2024, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $50. Previously, UBS started tracking the stock with Buy rating on October 16, 2024, and set its price target to $43. On October 10, 2024, Guggenheim initiated with a Buy rating and assigned a price target of $40 on the stock. Needham reiterated its Buy rating and increased its price target to $33 on February 23, 2024. Raymond James downgraded its rating to a Mkt Perform. Scotiabank started tracking with a Sector Outperform rating for this stock on January 05, 2023, and assigned it a price target of $33. In a note dated January 07, 2022, Stephens initiated an Overweight rating and provided a target price of $52 on this stock.
Veracyte Inc experienced fluctuations in its stock price throughout the past year between $18.61 and $41.43. Currently, Wall Street analysts expect the stock to reach $35 within the next 12 months. Veracyte Inc [NASDAQ: VCYT] shares were valued at $41.10 at the most recent close of the market. An investor can expect a potential drop of -14.84% based on the average VCYT price forecast.
Analyzing the VCYT fundamentals
Trailing Twelve Months sales for Veracyte Inc [NASDAQ:VCYT] were 425.33M which represents 28.58% growth. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.01 and Total Capital is 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 40.29 points at the first support level, and at 39.47 for the second support level. However, for the 1st resistance point, the stock is sitting at 41.62, and for the 2nd resistance point, it is at 42.13.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Veracyte Inc [NASDAQ:VCYT] is 5.08. As well, the Quick Ratio is 4.79, while the Cash Ratio is 3.9. Considering the valuation of this stock, the price to sales ratio is 7.61, the price to book ratio is 2.71.
Transactions by insiders
Recent insider trading involved EASTHAM KARIN, Director, that happened on Nov 19 ’24 when 14731.0 shares were sold. Director, KARIN EASTHAM completed a deal on Nov 19 ’24 to buy 14731.0 shares. Meanwhile, Chief Financial Officer Chambers Rebecca sold 15275.0 shares on Nov 12 ’24.
